Knowledge Distillery

Evidence suggests a role for excessive inflammation in COVID-19 complications. Colchicine is an oral anti-inflammatory medication beneficial in gout,…

Though SARS-CoV-2 primarily targets the respiratory system, patients and survivors can suffer neurological symptoms. Yet, an unbiased understanding of…

SARS-CoV-2 neutralizing antibodies (NAbs) protect against COVID-19. A concern regarding SARS-CoV-2 antibodies is whether they mediate disease…

In addition to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans are also susceptible to six other coronaviruses, for which…

The aim of this study was to evaluate the role of baseline lymphocyte subset counts in predicting the outcome and severity of COVID-19 patients.

In this rapid communication, the authors present a global analysis of the spread of recently emerged SARS-CoV-2 variants and estimate changes in…

SARS-CoV-2 has undergone progressive change with variants conferring advantage rapidly becoming dominant lineages e.g. B.1.617. With apparent…

The objective of this retrospective cohort analysis was to evaluate the relation between diagnosis of COVID-19 with SARS-CoV-2 variant B.1.1.7 (also…

Incubation period is an important parameter to inform quarantine period and to study transmission dynamics of infectious diseases.

Over one year after its inception, the coronavirus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2…

Characterizing the kinetics of the antibody response to SARS‐CoV‐2 is of critical importance to developing strategies that may mitigate the public…

The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension exists that variants of concern (VOCs) may evade vaccine…